The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of iso...

Detaylı Bibliyografya
Asıl Yazarlar:	Carbonneau, M, M Gagné, L, Lalonde, M, Germain, M, Motorina, A, Guiot, M, Secco, B, Vincent, E, Tumber, A, Hulea, L, Bergeman, J, Oppermann, U, Jones, R, Laplante, M, Topisirovic, I, Petrecca, K, Huot, M, Mallette, F
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Springer Nature 2016

Benzer Materyaller

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
Yazar:: Teng, Xin, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
Yazar:: Mengyuan Cai, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
Yazar:: Lorenzo Galluzzi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
Yazar:: Vivek A. Hariharan, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Focused screening identifies different sensitivities of human TET oxygenases to the oncometabolite 2-hydroxyglutarate
Yazar:: Belle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
Yazar:: Brad Evans, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

Oncometabolites D- and L-2-hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions
Yazar:: Chen, Fangyi, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
Yazar:: Xinting Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

mTOR Signaling in Growth Control and Disease
Yazar:: Laplante, Mathieu, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Intracerebral Distribution of the Oncometabolite D-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis
Yazar:: Amanda Pickard, ve diğerleri
Baskı/Yayın Bilgisi: (2016-10-01)

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation
Yazar:: Mary Taub, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
Yazar:: Ryan Janke, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
Yazar:: Luyan Mu, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
Yazar:: Kexu Xiang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

An emerging role of mTOR in lipid biosynthesis
Yazar:: Laplante, Mathieu, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The emerging role of fumarate as an oncometabolite.
Yazar:: Yang, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
Yazar:: Luyuan Li, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Oncometabolites: linking altered metabolism with cancer.
Yazar:: Yang, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The Emerging Role of LPA as an Oncometabolite
Yazar:: Theodoros Karalis, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

The emerging role of fumarate as an oncometabolite
Yazar:: Ming eYang, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Hydroxyglutaric Acidemia
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (1992-09-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
Yazar:: Carolina Simioni, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Oncometabolites: A new insight for oncology
Yazar:: Fatemeh Khatami, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Autism and Hydroxyglutaric Aciduria
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2008-04-01)

The Roles of 2-Hydroxyglutarate
Yazar:: Xin Du, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Yazar:: Peterson, Timothy R., ve diğerleri
Baskı/Yayın Bilgisi: (2015)

The mTOR–lysosome axis at the centre of ageing
Yazar:: Julian M. Carosi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
Yazar:: George K. E. Umanah, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
Yazar:: Kim, HaEun, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
Yazar:: HaEun Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine.
Yazar:: Soumya K Kar, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

mTOR at the nexus of nutrition, growth, ageing and disease
Yazar:: Liu, Grace Y, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
Yazar:: Victor H. Villar, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Oncometabolite induced primary cilia loss in pheochromocytoma
Yazar:: O'Toole, SM, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

mTOR at the Transmitting and Receiving Ends in Tumor Immunity
Yazar:: Yakir Guri, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

mTOR, autophagy and reprogramming
Yazar:: Bor Luen eTang
Baskı/Yayın Bilgisi: (2014-01-01)

A Central Role for mTOR in Lipid Homeostasis
Yazar:: Lamming, Dudley W., ve diğerleri
Baskı/Yayın Bilgisi: (2016)